Carbidopa is used in the treatment of Parkinsonism because:
It decreases peripheral utilisation of L-dopa
Carbidopa is used in the treatment of Parkinsonism because:
It decreases peripheral utilisation of L-dopa
It decreases peripheral utilisation of L-dopa
It decreases peripheral utilisation of L-dopa